118 results on '"Oliver Rick"'
Search Results
2. Langzeitüberleben bei Krebs: Definitionen, Konzepte und Gestaltungsprinzipien von Survivorship-Programmen
- Author
-
Corinna Bergelt, Carsten Bokemeyer, Inken Hilgendorf, Thorsten Langer, Oliver Rick, Ulf Seifart, and Uwe Koch-Gromus
- Subjects
Public Health, Environmental and Occupational Health - Abstract
ZusammenfassungAufgrund von diagnostischen und therapeutischen Fortschritten in der Hämatologie und Onkologie und entsprechend steigenden Überlebensaussichten ist ein stetiger Zuwachs der Gruppe von Langzeitüberlebenden mit und nach Krebs (Cancer Survivor) in Deutschland zu verzeichnen. Obwohl das bereits vorhandene deutsche Gesundheitswesen vielfältige Versorgungsangebote vorhält, die auch für Langzeitüberlebende verfügbar sind, ist die Versorgungssituation dieser Gruppe nicht zufriedenstellend. So bedarf es zum einen der Entwicklung von Orientierungshilfen für Langzeitüberlebende, zum anderen sollten neue und innovative Versorgungsprogramme für Überlebende (Survivorship-Programme) entwickelt werden. Der Beitrag gibt einen Überblick über die Problematik, definiert relevante Begrifflichkeiten und formuliert Kernaspekte für die Ausgestaltung von Survivorship-Programmen für Langzeitüberlebende nach Krebserkrankung.
- Published
- 2022
3. Krebsbedingte kognitive Dysfunktion
- Author
-
Oliver Rick
- Subjects
Oncology ,Hematology - Published
- 2022
4. Oncologic Rehabilitation in the COVID-19 Pandemic: The Situation in Clinics
- Author
-
Oliver, Rick, Wilfried, Hoffmann, and Monika Anna, Steimann
- Subjects
Cancer Research ,Oncology ,Neoplasms ,Surveys and Questionnaires ,COVID-19 ,Humans ,Hematology ,Medical Oncology ,Pandemics - Abstract
Background: Oncological rehabilitation is an important pillar in the treatment of cancer patients. Due to the COVID-19 pandemic, this form of therapy is particularly challenged, as it relies heavily on group therapies. The aim of the study was to find out what impact the pandemic has had on oncological rehabilitation so far and how the rehabilitation clinics have dealt with it. Methods: A web-based survey was used to collect data from 14 oncological rehabilitation clinics on the impact of the COVID-19 pandemic on occupancy, staffing trends, and hygiene measures for the observation period from March 1, 2020, to February 28, 2021. The data were compared with the same period 1 year earlier. In addition, the compensatory measures taken with regard to therapy were recorded. Results: While only 15,272 patients were rehabilitated in the period under review, 21,257 patients were rehabilitated in the same period 1 year earlier. This corresponds to a decrease in occupancy of 28%. Three clinics were affected by temporary closures due to the pandemic. In 39% of the clinics, screening tests for patients had already been started for more than 8 months, while this was also offered to staff in only 23% of the clinics. With regard to changes in the therapeutic offer, more physiotherapeutic small groups with a reduced number of participants were used. This was also used in the area of sports therapy and education offers by 73% and 60% of the clinics, respectively. Overall, 92% of the participants assumed an economic recovery at the time of the survey. Conclusion: Despite a considerable decrease in occupancy in the oncological rehabilitation clinics, the therapies could be changed and carried out in a hygiene-compliant manner. Screening tests were offered at an early stage for patients as well as somewhat delayed for staff. The data show that pandemic-consistently changes in oncological rehabilitation are possible and that supply chains can be maintained.
- Published
- 2022
5. Global Sports and Contemporary China
- Author
-
Oliver Rick and Longxi Li
- Published
- 2023
6. Bedeutung der stufenweisen Wiedereingliederung für die Rückkehr an den Arbeitsplatz bei onkologischen Patienten
- Author
-
Oliver Rick
- Subjects
medicine.medical_specialty ,business.industry ,Rehabilitation ,MEDLINE ,Medical rehabilitation ,Return to work ,Screening questionnaire ,Physical therapy ,medicine ,Retrospective analysis ,In patient ,Oncology patients ,business ,Cohort study - Abstract
Zusammenfassung Ziel der Studie Die stufenweise Wiedereingliederung (stWE) ist seit vielen Jahren ein etabliertes Instrument zur Rückkehr an den Arbeitsplatz. Allerdings ist der Effekt bei Patienten mit onkologischen Erkrankungen ungeklärt. Zielsetzung der Studie war es, die Bedeutung der stWE nach einer stationären medizinischen Rehabilitation zu ermitteln. Methodik Im Rahmen einer Kohortenstudie wurden retrospektiv die Daten von 787 Patienten ausgewertet, die von 06/2012 bis 06/2019 eine medizinische Rehabilitation in der Klinik Reinhardshöhe durchgeführt haben. Die Patienten wurden routinemäßig 6 Monate nach Ende der medizinischen Rehabilitation kontaktiert und zur beruflichen Situation befragt. Die subjektive vom Patienten angegebene Erwerbsprognose wurde mittels des Würzburger Screening-Bogens erfasst. Ergebnis 485/787 Patienten (62%) hatten eine stufenweise Wiedereingliederung durchgeführt, 302/787 Patienten (38%) hatten dies nicht getan. Zum Zeitpunkt der Nachbefragung waren 456/485 Patienten mit stWE an den Arbeitsplatz zurückgekehrt, in der Gruppe ohne stWE taten dies nur 155/302 Patienten (94 vs. 51%; p Schlussfolgerung Wenngleich es sich um eine retrospektive Analyse von Routinedaten handelt, stellt sich die stWE als sehr starker positiver Prädiktor für die Rückkehr an den Arbeitsplatz dar. Die Nicht-Inanspruchnahme einer stWE ist wahrscheinlich durch weitere medizinische oder persönliche und in unserer Studie nicht kontrollierte Faktoren beeinflusst. Dies kann zur Überschätzung des Effektes geführt haben.
- Published
- 2021
7. Cycling in the Flattened City: Urban Assemblages and Digital Visual Research
- Author
-
Oliver Rick and Jacob J. Bustad
- Subjects
Sociology and Political Science ,Conceptualization ,Movement (music) ,05 social sciences ,0211 other engineering and technologies ,0507 social and economic geography ,021107 urban & regional planning ,Human Factors and Ergonomics ,02 engineering and technology ,Human-Computer Interaction ,Geography ,Arts and Humanities (miscellaneous) ,Aesthetics ,Assemblage (archaeology) ,Anatomy ,Cycling ,050703 geography ,Law ,Visual research - Abstract
As urban assemblage theory emphasizes a conceptualization of the city as movement, constituted through the processual interactions between different human and non-human actors. This approach has been recognized as potentially valuable for the study of active bodies in urban environments ( Rick and Bustad 2020 ). Moreover, this approach also encourages the development and implementation of innovative methodologies aimed at conveying the complexity of urban life ( McFarlane and Anderson 2011 ). This article contributes to this approach through the use of digital visual research methods while experiencing a monthly cycling event in Baltimore, Maryland. In particular, we discuss how GoPro cameras might be utilized within the study of the embodied experience of urban cycling, and how this experience demonstrates the assemblage of human, machine, and urban environment. Following Sumartojo and Pink (2017) , we describe how GoPro recordings of active urban embodiment work to provide more than second-hand representations of others’ experiences, and instead can serve to collect and analyze ‘traces’ of the assemblages of urban physical cultures.
- Published
- 2021
8. Einfluss klinischer, sozialmedizinischer und psychologischer Faktoren auf die berufliche Reintegration von Patientinnen mit Brustkrebs 6 Monate nach der Rehabilitation
- Author
-
Christian Hoppe, Timm Dauelsberg, Klaus Fliessbach, Jürgen Pfitzner, Christa Kerschgens, Reiner Caspari, Oliver Rick, Gabriele Götz-Keil, Holger G. Hass, Monika Reuß-Borst, and Volker König
- Subjects
Gynecology ,medicine.medical_specialty ,business.industry ,Medizinische rehabilitation ,Rehabilitation ,Medicine ,Medical rehabilitation ,business ,Return to work - Abstract
Zusammenfassung Ziel der Studie Die Mehrzahl der Patientinnen mit nicht-metastasiertem Brustkrebs kehrt nach der Tumortherapie wieder ins Erwerbsleben zurück. In nationalen und internationalen Studien wird eine Rate von bis zu 80% angegeben, die allerdings in Abhängigkeit vom untersuchten Studienkollektiv und den verschiedenen Sozialsystemen erheblich schwanken kann. Unklar ist hingegen, wie viele Patientinnen nach einer medizinischen Rehabilitation wieder ins Erwerbsleben reintegriert werden und welche klinischen, soziodemografischen und psychologischen Faktoren dabei eine Rolle spielen. Methodik Im Rahmen einer multizentrischen Studie wurden bei Patientinnen mit Brustkrebs zu Beginn ihrer medizinischen Rehabilitation die klinischen und soziodemografischen Daten erhoben. Außerdem wurden subjektiv erlebte Defizite der Aufmerksamkeitsleistung (FEDA), depressive Symptome (PHQ-9) und die gesundheitsbezogene Lebensqualität (EORTC QLQ-C30) mittels standardisierter Fragebögen erfasst. Die kognitive Leistungsfähigkeit wurde zusätzlich mittels einer computergestützten Testbatterie (NeuroCog FX) untersucht. Eine Nachbefragung erfolgte 6–9 Monate nach der medizinischen Rehabilitation. Auch die subjektive Einschätzung der eigenen kognitiven Leistungsfähigkeit (FEDA) wurde zu diesem Zeitpunkt erneut erhoben. Ergebnisse Es konnten 396 der ursprünglich 476 Patientinnen in die Studie eingeschlossen werden. Bei der Nachbefragung waren 323/396 Patientinnen (82%) wieder erwerbstätig. In einem Regressionsmodell erwiesen sich im Hinblick auf die berufliche Reintegration vor allem soziodemografische Faktoren als positiv prädiktiv: Erwerbstätigkeit zum Zeitpunkt der Tumordiagnose, nach der medizinischen Rehabilitation erhaltener Arbeitsplatz, Angestelltenstatus und stufenweise Wiedereingliederung nach dem Hamburger Modell (Nagelkerke R2=0,685). Dieses Modell konnte durch Hinzufügung psychologischer Variablen nicht verbessert werden. Die subjektiven Patientenangaben in allen Fragebögen waren hoch korreliert (r>0,57; p Schlussfolgerung Die weit überwiegende Mehrheit der Patientinnen mit Brustkrebs kehrt nach einer medizinischen Rehabilitation ins Erwerbsleben zurück. Soziodemografische Faktoren spielen dabei eine entscheidende Rolle. Das hier entwickelte Regressionsmodell unter Einbeziehung des Erwerbsstatus, der beruflichen Ausrichtung und der stufenweisen Wiedereingliederung hat prädiktive Bedeutung und kann in der medizinischen Rehabilitation genutzt werden.
- Published
- 2021
9. Indikationen zur onkologischen Rehabilitation
- Author
-
Oliver Rick and Timm Dauelsberg
- Subjects
Gynecology ,021110 strategic, defence & security studies ,medicine.medical_specialty ,business.industry ,05 social sciences ,050602 political science & public administration ,0211 other engineering and technologies ,Medicine ,02 engineering and technology ,business ,0506 political science - Abstract
Trotz guter Etablierung der onkologischen Rehabilitation in die Versorgungskette von Krebspatienten ist die Indikationsstellung vielen Kollegen in der Akutmedizin nicht prasent. Dies fuhrt dazu, dass Patienten, die von einer onkologischen Rehabilitation profitieren wurden, diese Therapieform nicht erhalten. Der vorliegende Beitrag soll beispielhaft die Indikation zur onkologischen Rehabilitation darstellen und somit Hilfestellung zum Einsatz bei bedurftigen Patienten geben. Bei der Publikation handelt es sich um eine Ubersichtsarbeit mittels unsystematischer Literaturrecherche und Expertenmeinungen. Indikationen zur onkologischen Rehabilitation werden dargestellt und zeigen die Sinnhaftigkeit bei entsprechend bedurftigen Patienten auf. Soweit vorhanden, werden die Aussagen evidenzbasiert dargestellt. Leider verfugt die onkologische Rehabilitation nach wie vor nicht uber eine spezifische und ausreichende Evidenzlage, sodass zu einigen Punkten nur Expertenmeinungen vorliegen. Trotz der eingeschrankten Evidenzlage der onkologischen Rehabilitation stellt diese Masnahme ein probates Mittel dar, um Patienten mit und nach einer Krebserkrankung fur ihren kommenden Lebensweg zu helfen. In diesem Zusammenhang sollen Moglichkeiten der Therapie von Folgestorungen vom Patienten selbst erlernt werden, um damit die Lebensqualitat zu verbessern. Durch die umfassende sozialmedizinische Kompetenz kann Patienten die Ruckfuhrung ins Erwerbsleben oder auch im medizinisch begrundeten Fall der Weg aus dem Erwerbsleben erleichtert werden. Ob die onkologische Rehabilitation diesen Anspruchen genugt, ist nach wie vor nicht durch vergleichende Untersuchungen abgesichert. Aus diesem Grund ist ein Forschungsvorhaben konzipiert worden, welches derzeit bei der Deutschen Forschungsgemeinschaft zur Beantragung einer finanziellen Forderung eingereicht wurde.
- Published
- 2020
10. Rehabilitation in Zeiten von COVID-19
- Author
-
Oliver Rick
- Subjects
medicine.medical_specialty ,business.industry ,Physical therapy ,medicine ,Schwerpunkt ,business - Published
- 2020
11. Wann ist die onkologische Rehabilitation sinnvoll?
- Author
-
Timm Dauelsberg and Oliver Rick
- Subjects
medicine.medical_specialty ,business.industry ,General surgery ,Medicine ,business - Published
- 2020
12. Rückkehr ins Erwerbsleben und medizinisch-beruflich orientierte Reha (MBOR) in der Onkologie
- Author
-
Oliver Rick and Monika Steimann
- Published
- 2022
13. Kognitive Dysfunktion
- Author
-
Oliver Rick and Volker König
- Published
- 2022
14. Onkologische Rehabilitation
- Author
-
Oliver Rick
- Published
- 2022
15. [Importance of Gradual Reintegration for Return to Work in Oncology Patients]
- Author
-
Oliver, Rick
- Subjects
Cohort Studies ,Return to Work ,Germany ,Neoplasms ,Humans ,Retrospective Studies - Abstract
Gradual reintegration has been an established tool for return to work for many years. However, the effect is unclear in patients with oncological diseases. The objective of this study was to determine the significance of gradual reintegration after inpatient medical rehabilitation.Within the framework of a cohort study, data of 787 patients who underwent medical rehabilitation at Clinic Reinhardshöhe from 06/2012 to 06/2019 were retrospectively analyzed. Patients were routinely contacted 6 months after the end of medical rehabilitation and asked about their occupational situation. The subjective employment prognosis stated by the patient was recorded using the Würzburg Screening Questionnaire.485/787 patients (62%) had undergone gradual reintegration, 302/787 patients (38%) had not. At the time of the follow-up survey, 456/485 patients with gradual reintegration had returned to work, while only 155/302 patients in the group without gradual reintegration had done so (94 vs. 51%; p0.001). As a positive predictor of return to work, gradual reintegration was found to be by far the strongest factor (OR 20.21; 95% CI 8.605-47.065).Although this is a retrospective analysis of routine data, gradual reintegration turns out to be a very strong predictor of return to work. Nonuse of stWE is likely influenced by other medical or personal factors not controlled for in our study. This may have led to overestimation of the effect.Die stufenweise Wiedereingliederung (stWE) ist seit vielen Jahren ein etabliertes Instrument zur Rückkehr an den Arbeitsplatz. Allerdings ist der Effekt bei Patienten mit onkologischen Erkrankungen ungeklärt. Zielsetzung der Studie war es, die Bedeutung der stWE nach einer stationären medizinischen Rehabilitation zu ermitteln.Im Rahmen einer Kohortenstudie wurden retrospektiv die Daten von 787 Patienten ausgewertet, die von 06/2012 bis 06/2019 eine medizinische Rehabilitation in der Klinik Reinhardshöhe durchgeführt haben. Die Patienten wurden routinemäßig 6 Monate nach Ende der medizinischen Rehabilitation kontaktiert und zur beruflichen Situation befragt. Die subjektive vom Patienten angegebene Erwerbsprognose wurde mittels des Würzburger Screening-Bogens erfasst.485/787 Patienten (62%) hatten eine stufenweise Wiedereingliederung durchgeführt, 302/787 Patienten (38%) hatten dies nicht getan. Zum Zeitpunkt der Nachbefragung waren 456/485 Patienten mit stWE an den Arbeitsplatz zurückgekehrt, in der Gruppe ohne stWE taten dies nur 155/302 Patienten (94 vs. 51%; p0,001). Als positiver Prädiktor für die Rückkehr an den Arbeitsplatz fand sich die stWE als mit Abstand stärkster Faktor (OR 20,21; 95%-KI 8,605–47,065).Wenngleich es sich um eine retrospektive Analyse von Routinedaten handelt, stellt sich die stWE als sehr starker positiver Prädiktor für die Rückkehr an den Arbeitsplatz dar. Die Nicht-Inanspruchnahme einer stWE ist wahrscheinlich durch weitere medizinische oder persönliche und in unserer Studie nicht kontrollierte Faktoren beeinflusst. Dies kann zur Überschätzung des Effektes geführt haben.
- Published
- 2021
16. Diversity and Inclusion in Social Media and Sport
- Author
-
Jacob J. Bustad and Oliver Rick
- Subjects
media_common.quotation_subject ,Social media ,Sociology ,Social science ,Inclusion (education) ,Diversity (politics) ,media_common - Published
- 2021
17. Systemische Krebstherapien während der onkologischen Rehabilitation
- Author
-
Florian Strasser and Oliver Rick
- Subjects
Gynecology ,medicine.medical_specialty ,business.industry ,medicine ,business - Abstract
In vielen Rehabilitationskliniken werden keine Chemo- oder Immuntherapien wahrend der Rehabilitation durchgefuhrt. Onkologie-spezifische Rehabilitationsbehandlungen mussen in die Behandlungspfade der modernen Onkologie integriert werden, dazu konnen systemische Krebstherapien wahrend einer stationaren Rehabilitation gehoren.
- Published
- 2019
18. Cancer-Survivorship-Care — Basis für die Qualität des Langzeitüberlebens
- Author
-
Oliver Rick
- Subjects
Cancer survivorship ,Gynecology ,medicine.medical_specialty ,business.industry ,medicine ,business - Abstract
Immer mehr Patienten uberleben ihre Tumorerkrankung auch langfristig. Die Rehabilitation ist heute daher aktiver Bestandteil der onkologischen Behandlung. Als dritte Saule stellt sie quasi den Startschuss fur Cancer-Survivorship-Care dar.
- Published
- 2019
19. Ausgewählte somatische Aspekte im Rahmen von 'cancer survivorship'
- Author
-
Monika Steimann, C. Schmalz, and Oliver Rick
- Subjects
Gynecology ,021110 strategic, defence & security studies ,medicine.medical_specialty ,business.industry ,05 social sciences ,050602 political science & public administration ,0211 other engineering and technologies ,medicine ,02 engineering and technology ,business ,0506 political science - Abstract
Langzeitfolgen stellen einen wesentlichen Bestandteil von „cancer survivorship“ dar. Insbesondere sind dabei die zytostatikainduzierte Polyneuropathie (CIPN), die kognitive Dysfunktion und strahlentherapeutische Folgen zu nennen. Im vorliegenden Beitrag werden die genannten Langzeitfolgen von Krebsuberlebenden dargestellt. Die CIPN ist ein haufiges Problem und hat einen individuell unterschiedlichen Verlauf. Durch aktive Bewegungstherapie und stimulierende Therapien konnen die Nervenfunktionen in der Regeneration beschleunigt werden. Die Ergebnisse hierfur sind allerdings nicht ausreichend, um klare therapeutische Empfehlungen aussprechen zu konnen. Die kognitive Dysfunktion stellt ebenfalls eine relevante und lange unterschatzte Langzeitfolge nach Krebserkrankung dar. In der Pathogenese spielt eine depressive Komponente eine wichtige Rolle. Die besten Daten zur Therapie existieren fur ein webgestutztes kognitives Trainingsprogramm. Im Laufe der letzten 3 Jahrzehnte sind die Toxizitaten durch Strahlentherapie deutlich zuruckgegangen. Insbesondere die mukosalen Folgen sowie Geschmacksstorungen sind fur die Patienten oftmals sehr belastend. Die therapeutischen Ansatze beschranken sich auf die Supportivmedizin. Die CIPN, die kognitive Dysfunktion und die strahlentherapeutischen Folgen sind Aspekte, die bei der Langzeitbetreuung von Krebspatienten eine wesentliche Rolle spielen und in Programmen zu „cancer survivorship“ implementiert werden sollten. Weitere Studien zur Behandlung dieser z. T. multifaktoriellen Funktionsstorungen sind dringend erforderlich, da die Datenlage diesbezuglich noch nicht ausreichend ist, um Therapiestandards zu formulieren.
- Published
- 2019
20. Onkologische Rehabilitation — Basis für die Qualität des Langzeitüberlebens
- Author
-
Oliver Rick
- Subjects
Gynecology ,medicine.medical_specialty ,Surgical oncology ,business.industry ,Medicine ,business - Abstract
Immer mehr Patienten uberleben auch langfristig ihre Tumorerkrankung. Die Rehabilitation ist heute daher ein aktiver Bestandteil der onkologischen Behandlung. Als dritte Saule stellt sie quasi den Startschuss fur Cancer-Survivorship-Care dar.
- Published
- 2018
21. Welche Brustkrebspatientin nimmt an einer onkologischen Rehabilitation teil?
- Author
-
Sandrina Bachmaier and Oliver Rick
- Subjects
Gynecology ,medicine.medical_specialty ,business.industry ,medicine ,business - Published
- 2021
22. [Role of Clinical, Sociomedical and Psychological Factors on Return to Work of Patients with Breast Cancer 6 Months after Rehabilitation]
- Author
-
Oliver, Rick, Monika, Reuß-Borst, Timm, Dauelsberg, Holger G, Hass, Volker, König, Reiner, Caspari, Gabriele, Götz-Keil, Jürgen, Pfitzner, Christa, Kerschgens, Klaus, Fliessbach, and Christian, Hoppe
- Subjects
Employment ,Return to Work ,Germany ,Surveys and Questionnaires ,Quality of Life ,Humans ,Breast Neoplasms ,Female - Abstract
The majority of patients with non-metastatic breast cancer return to work after tumor therapy. A rate of up to 80% is given in national and international studies, which can vary considerably depending on the study population and the various social systems. However, it is unclear how many patients are reintegrated into work after medical rehabilitation and which clinical, sociodemographic and psychological factors play a role.In a multicentre study, clinical and sociodemographic data were collected from breast cancer patients at the beginning of their medical rehabilitation. Subjectively experienced deficits in attention performance (FEDA), depressive symptoms (PHQ-9) and health-related quality of life (EORTC QLQ-C30) were recorded using standardized questionnaires. The cognitive performance was also examined using a computer-based test battery (NeuroCog FX). A follow-up survey was carried out 6-9 months after medical rehabilitation. The subjective assessment of one's own cognitive performance (FEDA) was recorded again at this time.396 of the originally 476 patients were included in the study. In the follow-up survey, 323/396 patients (82%) were again employed. In a regression model, sociodemographic factors proved to be particularly predictive with regard to occupational reintegration: employment at the time of the tumor diagnosis, job preserved after medical rehabilitation, employee status and gradual reintegration according to the Hamburg model (Nagelkerke RThe vast majority of breast cancer patients return to work after medical rehabilitation. Socio-demographic factors play a crucial role in this. The regression model developed here, including the employment status, professional orientation and gradual reintegration, is of predictive importance and can be used in medical rehabilitation.Die Mehrzahl der Patientinnen mit nicht-metastasiertem Brustkrebs kehrt nach der Tumortherapie wieder ins Erwerbsleben zurück. In nationalen und internationalen Studien wird eine Rate von bis zu 80% angegeben, die allerdings in Abhängigkeit vom untersuchten Studienkollektiv und den verschiedenen Sozialsystemen erheblich schwanken kann. Unklar ist hingegen, wie viele Patientinnen nach einer medizinischen Rehabilitation wieder ins Erwerbsleben reintegriert werden und welche klinischen, soziodemografischen und psychologischen Faktoren dabei eine Rolle spielen.Im Rahmen einer multizentrischen Studie wurden bei Patientinnen mit Brustkrebs zu Beginn ihrer medizinischen Rehabilitation die klinischen und soziodemografischen Daten erhoben. Außerdem wurden subjektiv erlebte Defizite der Aufmerksamkeitsleistung (FEDA), depressive Symptome (PHQ-9) und die gesundheitsbezogene Lebensqualität (EORTC QLQ-C30) mittels standardisierter Fragebögen erfasst. Die kognitive Leistungsfähigkeit wurde zusätzlich mittels einer computergestützten Testbatterie (NeuroCog FX) untersucht. Eine Nachbefragung erfolgte 6–9 Monate nach der medizinischen Rehabilitation. Auch die subjektive Einschätzung der eigenen kognitiven Leistungsfähigkeit (FEDA) wurde zu diesem Zeitpunkt erneut erhoben.Es konnten 396 der ursprünglich 476 Patientinnen in die Studie eingeschlossen werden. Bei der Nachbefragung waren 323/396 Patientinnen (82%) wieder erwerbstätig. In einem Regressionsmodell erwiesen sich im Hinblick auf die berufliche Reintegration vor allem soziodemografische Faktoren als positiv prädiktiv: Erwerbstätigkeit zum Zeitpunkt der Tumordiagnose, nach der medizinischen Rehabilitation erhaltener Arbeitsplatz, Angestelltenstatus und stufenweise Wiedereingliederung nach dem Hamburger Modell (Nagelkerke RDie weit überwiegende Mehrheit der Patientinnen mit Brustkrebs kehrt nach einer medizinischen Rehabilitation ins Erwerbsleben zurück. Soziodemografische Faktoren spielen dabei eine entscheidende Rolle. Das hier entwickelte Regressionsmodell unter Einbeziehung des Erwerbsstatus, der beruflichen Ausrichtung und der stufenweisen Wiedereingliederung hat prädiktive Bedeutung und kann in der medizinischen Rehabilitation genutzt werden.
- Published
- 2021
23. Management of Germ Cell Tumours of the Testes in Adult Patients: German Clinical Practice Guideline, PART II − Recommendations for the Treatment of Advanced, Recurrent, and Refractory Disease and Extragonadal and Sex Cord/Stromal Tumours and for the Management of Follow-Up, Toxicity, Quality of Life, Palliative Care, and Supportive Therapy
- Author
-
Jens Bedke, Oliver Rick, Heinrich Recken, Hans Ulrich Schmelz, Stefan Schweyer, Stefanie Seeling, Susanne Krege, Timur Ohloff, Sabine Kliesch, Thorsten Diemer, Johannes Classen, K. Oechsle, Christoph Oing, Christian Ruf, Julia Heinzelbecker, Matthias Gockel, Ulrich Otto, Maike de Wit, Christian Wittekind, Stefanie Schmidt, Rainer Souchon, Marko Kornmann, Arndt-Christian Müller, Renate Pichler, Anja Lorch, Friedemann Zengerling, Glen Kristiansen, Roger Zillmann, Jörg Kotzerke, Clemens Aigner, Axel Heidenreich, Peter Albers, Christian Winter, Carsten Bokemeyer, Walter Albrecht, Sascha Kaufmann, David Pfister, Mark Schrader, Thomas Hermanns, Bernt Göckel-Beining, Heinz Schmidberger, Yvonne Rudolph, Kathleen Herkommer, Dirk Beyersdorff, Klaus-Peter Dieckmann, Doris Wilborn, Anette Dieing, Oliver W. Hakenberg, Jonas Busch, Matthias Beintker, Dirk-Henrik Zermann, and Joachim Schirren
- Subjects
Male ,Germ cell tumour of the testes ,Palliative care ,medicine.medical_treatment ,Medizin ,030232 urology & nephrology ,Aftercare ,Review ,Guideline ,Metastasis ,0302 clinical medicine ,Medicine ,Neoplasm Metastasis ,Stromal tumours ,Germ cell tumour of the testes, Seminoma, Non-seminoma, Metastasis, Extragonadal tumours , Stromal tumours, Therapy ,Rehabilitation ,Follow-up ,Palliative Care ,Neoplasms, Germ Cell and Embryonal ,Seminoma ,ddc ,030220 oncology & carcinogenesis ,Practice Guidelines as Topic ,Adult ,medicine.medical_specialty ,Extragonadal ,Urology ,Non-seminoma ,Extragonadal tumours ,Supportive therapy ,03 medical and health sciences ,Quality of life (healthcare) ,Testicular Neoplasms ,Humans ,Sex Cord-Gonadal Stromal Tumors ,ddc:610 ,Intensive care medicine ,Neoplasm Staging ,Inpatient care ,Toxicity ,business.industry ,medicine.disease ,Supportive psychotherapy ,Systematic review ,Quality of Life ,Therapy ,Neoplasm Recurrence, Local ,business - Abstract
Objectives: We developed the first German evidence- and consensus-based clinical guideline on diagnosis, treatment, and follow-up of germ cell tumours (GCT) of the testes in adult patients. We present the guideline content in 2 separate publications. The present second part summarizes therecommendations for the treatment of advanced disease stages and for the management of follow-up and late effects. Materials and Methods: An interdisciplinary panel of 42 experts including 1 patient representative developed the guideline content. Clinical recommendations and statements were based on scientific evidence and expert consensus. For this purpose, evidence tables for several review questions, which were based on systematic literature searches (last search in March 2018), were provided. Thirty-one experts, who were entitled to vote, rated the final clinical recommendations and statements. Results: Here we present the treatment recommendations separately for patients with metastatic seminoma and non-seminomatous GCT (stages IIA/B and IIC/III), for restaging and treatment of residual masses, and for relapsed and refractory disease stages. The recommendations also cover extragonadal and sex cord/stromal tumours, the management of follow-up and toxicity, quality-of-life aspects, palliative care, and supportive therapy. Conclusion: Physicians and other medical service providers who are involved in the diagnostics, treatment, and follow-up of GCT (all stages, outpatient and inpatient care as well as rehabilitation) are the users of the present guideline. The guideline also comprises quality indicators for measuring the implementation of the guideline recommendations in routine clinical care; these data will be presented in a future publication.
- Published
- 2021
24. Malignome des Urogenitaltrakts
- Author
-
Anja Lorch and Oliver Rick
- Published
- 2021
25. Management of Germ Cell Tumours of the Testis in Adult Patients. German Clinical Practice Guideline Part I: Epidemiology, Classification, Diagnosis, Prognosis, Fertility Preservation, and Treatment Recommendations for Localized Stages
- Author
-
Rainer Souchon, Anja Lorch, Oliver W. Hakenberg, Renate Pichler, Oliver Rick, Jonas Busch, Matthias Beintker, Stefanie Schmidt, Heinz Schmidberger, Kathleen Herkommer, Joachim Schirren, Dirk Beyersdorff, Klaus-Peter Dieckmann, Christoph Oing, Julia Heinzelbecker, Johannes Classen, Susanne Krege, Timur Ohloff, Stefan Schweyer, Ulrich Otto, Glen Kristiansen, Sabine Kliesch, Jörg Kotzerke, Heinrich Recken, Christian Winter, Stefanie Seeling, Doris Wilborn, Christian Wittekind, Peter Albers, Christian Ruf, Hans Ulrich Schmelz, Matthias Gockel, Walter Albrecht, Thomas Hermanns, Maike de Wit, Bernt Göckel-Beining, Thorsten Diemer, Arndt-Christian Müller, K. Oechsle, David Pfister, Dirk-Henrik Zermann, Roger Zillmann, Marko Kornmann, Axel Heidenreich, Clemens Aigner, Friedemann Zengerling, Carsten Bokemeyer, Sascha Kaufmann, Mark Schrader, Anette Dieing, Yvonne Rudolph, and Jens Bedke
- Subjects
Adult ,Male ,medicine.medical_specialty ,Staging ,Referral ,Urology ,Medizin ,030232 urology & nephrology ,Review ,Germ cell tumour of the testis ,Scientific evidence ,03 medical and health sciences ,0302 clinical medicine ,Testicular Neoplasms ,Diagnosis ,Epidemiology ,Humans ,Medicine ,ddc:610 ,Fertility preservation ,Intensive care medicine ,Neoplasm Staging ,Clinical practice guideline ,business.industry ,Intratubular germ cell neoplasia ,Fertility Preservation ,Guideline ,Seminoma ,Evidence-based medicine ,Neoplasms, Germ Cell and Embryonal ,Prognosis ,medicine.disease ,ddc ,030220 oncology & carcinogenesis ,Practice Guidelines as Topic ,Germ cell tumour of the testis, Diagnosis, Prognosis, Staging, Fertility preservation, Clinical practice guideline ,business - Abstract
Introduction: This is the first German evidence- and consensus-based clinical guideline on diagnosis, treatment, and follow-up on germ cell tumours (GCTs) of the testis in adult patients. We present the guideline content in two publications. Part I covers the topic’s background, methods, epidemiology, classification systems, diagnostics, prognosis, and treatment recommendations for the localized stages. Methods: An interdisciplinary panel of 42 experts including 1 patient representative developed the guideline content. Clinical recommendations and statements were based on scientific evidence and expert consensus. For this purpose, evidence tables for several review questions, which were based on systematic literature searches (last search was in March 2018) were provided. Thirty-one experts entitled to vote, rated the final clinical recommendations and statements. Results: We provide 161 clinical recommendations and statements. We present information on the quality of cancer care and epidemiology and give recommendations for staging and classification as well as for diagnostic procedures. The diagnostic recommendations encompass measures for assessing the primary tumour as well as procedures for the detection of metastases. One chapter addresses prognostic factors. In part I, we separately present the treatment recommendations for germ cell neoplasia in situ, and the organ-confined stages (clinical stage I) of both seminoma and nonseminoma. Conclusion: Although GCT is a rare tumour entity with excellent survival rates for the localized stages, its management requires an interdisciplinary approach, including several clinical experts. Quality of care is highly related to institutional expertise and can be reassured by established online-based second-opinion boards. There are very few studies on diagnostics with good level of evidence. Treatment of metastatic GCTs must be tailored to the risk according to the International Germ Cell Cancer Collaboration Group classification after careful diagnostic evaluation. An interdisciplinary approach as well as the referral of selected patients to centres with proven experience can help achieve favourable clinical outcomes.
- Published
- 2020
26. Critiquing Anthropocentric Media Coverage of the COVID-19 Sport 'Hiatus'
- Author
-
Oliver Rick, Jacob J. Bustad, and Samuel M. Clevenger
- Subjects
Hegemony ,Coronavirus disease 2019 (COVID-19) ,Communication ,05 social sciences ,Media coverage ,Environmental ethics ,030229 sport sciences ,Capitalism ,Hiatus ,03 medical and health sciences ,0302 clinical medicine ,Anthropocentrism ,Framing (social sciences) ,Political science ,Tourism, Leisure and Hospitality Management ,0502 economics and business ,Narrative ,Business and International Management ,050212 sport, leisure & tourism - Abstract
This commentary highlights a recent trend of anthropocentrism (a focus on human-centered interests and activities) in the media coverage in the United States and Europe on the disruption of the contemporary sports industry caused by the COVID-19 pandemic. The authors argued that the coverage promotes anthropocentric narratives by framing the pandemic as an external force causing a temporary and unforeseen “hiatus” in the sports industry. As a result, media consumers learn about human interest stories associated with consumer demand and industry adaptation: stories that renormalize, rather than question, the sports industry in its current and hegemonic form. Such media discourses bypass an opportunity to consider the longstanding entanglements of human and nonhuman actors in sporting contexts, rethink sport through environmental and nonhuman perspectives, and, ultimately, advance more progressive, democratic politics. The commentary employs a posthumanist lens to critique the recent anthropocentric media coverage, highlighting the ways in which it reproduces the dualist logic of neoliberal capitalism and deflects attention to the human and nonhuman relations that have always existed in contexts of sport and human physicality.
- Published
- 2020
- Full Text
- View/download PDF
27. Adressen
- Author
-
Kurt Possinger, Anne C. Regierer, Jan Eucker, Annette Dieing, Bernd Flath, Gunnar Folprecht, Michael Geißler, Florian Heidel, Erhard Hiller, Andreas Hochhaus, Kai Hübel, Henning Jann, Christian Jehn, Ulrich Keilholz, Konrad Klinghammer, Wolfgang Knauf, Hans-Jochem Kolb, Hannes Kroenlein, Anne Sophie Kubasch, Diana Lüftner, Matthias Möhlig, Ralph Naumann, Helmut Oettle, null Oettle, null Mayer, Ulrich-Frank Pape, Uwe Platzbecker, Andreas Rank, Peter Reichardt, Oliver Rick, Damian Rieke, Hanno Riess, Markus Ruhnke, Markus Schaich, Andreas Schalhorn, Ann-Kristin Schmälter, Alexander Schmittel, Christian Scholz, Hubert Schrezenmeier, Carsten-Oliver Schulz, Dorothee Speiser, and Bertram Wiedenmann
- Published
- 2020
28. Gynäkologische Tumoren
- Author
-
Kurt Possinger, Anne C. Regierer, Jan Eucker, Annette Dieing, Bernd Flath, Gunnar Folprecht, Michael Geißler, Florian Heidel, Erhard Hiller, Andreas Hochhaus, Kai Hübel, Henning Jann, Christian Jehn, Ulrich Keilholz, Konrad Klinghammer, Wolfgang Knauf, Hans-Jochem Kolb, Hannes Kroenlein, Anne Sophie Kubasch, Diana Lüftner, Matthias Möhlig, Ralph Naumann, Helmut Oettle, Ulrich-Frank Pape, Uwe Platzbecker, Andreas Rank, Peter Reichardt, Oliver Rick, Damian Rieke, Hanno Riess, Markus Ruhnke, Markus Schaich, Andreas Schalhorn, Ann-Kristin Schmälter, Alexander Schmittel, Christian Scholz, Hubert Schrezenmeier, Carsten-Oliver Schulz, Dorothee Speiser, and Bertram Wiedenmann
- Published
- 2020
29. 7. Is This the Beginning of the End? Small Colleges and Universities Are Questioning the Value of an NCAA Program for Their Student Body
- Author
-
Oliver Rick
- Subjects
Mathematics education ,Psychology ,Value (mathematics) - Published
- 2019
30. NeuroCog FX study: A multicenter cohort study on cognitive dysfunction in patients with early breast cancer
- Author
-
R. Caspari, V. König, Oliver Rick, M. Reuß-Borst, C. Hoppe, J. Pfitzner, K. Fliessbach, C. Kerschgens, T. Dauelsberg, G. Götz-Keil, and H. Hass
- Subjects
Adult ,Oncology ,Cancer Research ,medicine.medical_specialty ,Health Status ,medicine.medical_treatment ,Breast Neoplasms ,Experimental and Cognitive Psychology ,Neuropsychological Tests ,Cohort Studies ,03 medical and health sciences ,0302 clinical medicine ,Breast cancer ,Cancer Survivors ,Quality of life ,Germany ,Surveys and Questionnaires ,Internal medicine ,medicine ,Humans ,Cognitive Dysfunction ,In patient ,030212 general & internal medicine ,Effects of sleep deprivation on cognitive performance ,Neuropsychological assessment ,Early Detection of Cancer ,Depression (differential diagnoses) ,Early breast cancer ,Rehabilitation ,medicine.diagnostic_test ,Depression ,business.industry ,Retrospective cohort study ,Cognition ,Hematology ,Middle Aged ,medicine.disease ,Psychiatry and Mental health ,Cross-Sectional Studies ,030220 oncology & carcinogenesis ,Quality of Life ,Female ,business ,030217 neurology & neurosurgery ,Cohort study - Abstract
10061 Background: Many breast cancer patients complain about cognitive dysfunction (CD) with mnestic and attentional deficits. These complaints persist even after completion of therapy in approximately one third of the patients and affects both social life and working capacity. The exact nature and genesis of CD in breast cancer patients is still not fully understood and risk factors are not yet described. Methods: To determine CD and risk factors, we used the computer-based neuropsychological test NeuroCog-FX during a three weeks oncological rehabilitation in breast cancer patients. Eight subtests addressed attention, working memory, verbal and figural memory, and language. Test duration was < 30 minutes. A cognitive deficit was diagnosed if at least one subtest was clearly below average (score < M - 1.5 SD) of the normative age group. The data on cognitive function were correlated with the level of depression (PHQ-9 test), QoL (EORTC QLQ-30) and clinical parameters (nodal status, chemo-/radiotherapy and endocrine therapy). Results: From February 2013 to December 2014 a total of 476 patients were recruited in 9 oncological rehabilitation centers in Germany. NeuroCog-FX was used to examine 439 patients. Median age was 50 years (range: 24-62 years); 93% of patients had early tumor stage (T0-T2) and 67% were node-negative. Sixty-one percent of the patients received chemotherapy while 84% of the subjects underwent radiotherapy. CD was found in 59% and a moderate to severe depression in 38% of the patients. The severity of depression was correlated with slower reaction times and reduced verbal memory performance. These two cognitive parameters were also associated with a reduced global health status and a reduced physical function score on the EORTC-QLQ30 questionnaire suggesting an impact of cognitive deficits on quality of life. Cognitive function was not associated with type of treatment or node status. Conclusions: In this large and homogeneous cohort of breast cancer patients, CD has been shown in most of the subjects using a valid test method. CD was associated with depression and reduced quality of life. Neither tumor therapy nor other clinical parameters had a significant impact on development of CD.
- Published
- 2018
31. Kognitive Dysfunktionen bei Krebspatienten
- Author
-
Oliver Rick
- Subjects
Gynecology ,medicine.medical_specialty ,business.industry ,medicine ,business - Abstract
Eine kognitive Dysfunktion (KD) in Form von Konzentrations- und Gedachtnisstorungen wird bei Krebspatienten haufig beobachtet. Besonders intensiv untersucht wurden in dieser Hinsicht Frauen nach einer Brustkrebserkrankung. Bei ihnen fanden sich hohe Raten von KD. Erst in den letzten Jahren wurde dieser relevanten Funktionsstorung mehr Bedeutung beigemessen.
- Published
- 2017
32. Oncological Rehabilitation
- Author
-
Oliver, Rick, Timm, Dauelsberg, and Eva-Maria, Kalusche-Bontemps
- Subjects
Cancer Research ,Depression ,Hematology ,Medical Oncology ,03 medical and health sciences ,Return to Work ,0302 clinical medicine ,Cancer Survivors ,Oncology ,Germany ,Neoplasms ,030220 oncology & carcinogenesis ,Quality of Life ,Humans ,030212 general & internal medicine ,Fatigue ,Stress, Psychological - Abstract
An increasing number of patients are living with or surviving cancer due to improvements in detection and treatment. However, patients who survive cancer may experience functional disabilities that impact on health, quality of life and ability to work. For example, physical disorders may include fatigue, reduced muscle strength, cognitive dysfunction, paresthesia or nutrition problems, while mental symptoms may include anxiety, depression, fear of relapse or insomnia. Multidimensional oncological rehabilitation programs have been developed to address these disabilities and to help cancer patients and long-term survivors to reduce morbidity and to improve quality of life. There has been evidence showing that multidisciplinary oncological rehabilitation interventions involving physical, psycho-educational and vocational components led to a better quality of life and a higher rate of return to work than just usual care. In Germany, oncological rehabilitation is an integral part of the healthcare system and part of a modern cancer treatment that immediately follows operation, medical treatment or radiotherapy. Furthermore, it can be used if functional disabilities still remain years after cancer treatment. This review describes the German history and legal basis of oncological rehabilitation as well as the contents of and the evidence for this comprehensive and interdisciplinary treatment.
- Published
- 2017
33. Contents Vol. 40, 2017
- Author
-
Concetta Laliscia, Stefan Feiten, Emanuela Parietti, Gabriele Calaminus, Ines Cafaro, Oliver Rick, Monika Reuss-Borst, Ulf Seifart, Oswald Burkhard, Bernhard Wörmann, Eva-Maria Kalusche-Bontemps, Timm Dauelsberg, Amelia Barcellini, Ali Montazeri, Desiree Grabow, Mario Miniati, Fabiola Paiar, Shahpar Haghighat, Maria Grazia Fabrini, Davide Baldaccini, Jan Schmielau, Rudolf Weide, Diana Steinmann, Riccardo Morganti, Alipasha Meysami, Angiolo Gadducci, Thorsten Langer, Marcel Reiser, Peter Ehscheidt, Geothy Chakupurakal, Monika Steimann, Hossein Yari, and Druck
- Subjects
Cancer Research ,Oncology ,Hematology - Published
- 2017
34. 'Rehabilitative Maßnahmen werden fortgeführt, Patienten regulär entlassen'
- Author
-
Oliver Rick and Sandrina Bachmaier
- Subjects
business.industry ,Rehabilitation ,Medicine ,General Medicine ,Medical emergency ,business ,medicine.disease - Published
- 2020
35. Magnetic field therapy in patients with cytostatics-induced polyneuropathy: A prospective randomized placebo-controlled phase-III study
- Author
-
Georg Geiger, Ulrike von Hehn, Hermann Dertinger, Oliver Rick, and Eberhard Mikus
- Subjects
medicine.medical_specialty ,Physiology ,business.industry ,Biophysics ,Context (language use) ,General Medicine ,Placebo ,medicine.disease ,Nerve conduction velocity ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,Peripheral neuropathy ,Randomized controlled trial ,law ,030220 oncology & carcinogenesis ,Internal medicine ,Neuropathic pain ,medicine ,Clinical endpoint ,Physical therapy ,Radiology, Nuclear Medicine and imaging ,business ,Polyneuropathy ,030217 neurology & neurosurgery - Abstract
No causal treatment for chemotherapy-induced peripheral neuropathy (CIPN) is known. Therefore, there is an urgent need to develop a therapy for CIPN. Only scarce clinical data are available concerning magnetic field therapy (MFT) in this context. We conducted a unicentric, randomized, double-blind, placebo-controlled phase-III trial of an MFT device versus placebo. In this study, we randomized 44 patients with CIPN to two treatment groups, where 21 patients were treated with MFT (Group 1) and 23 patients received placebo (Group 2). We evaluated the efficacy of MFT at baseline (T1), after 3 weeks of study treatment (T2), and after 3 months of study treatment (T3). The primary endpoint was nerve conduction velocity (NCV), while secondary endpoints were the Common Toxicity Criteria (CTCAE) score and the Pain Detect End Score at T3. Seventeen of the patients in Group 1 and 14 patients in Group 2 completed the respective study treatment. The primary endpoint, significant improvement of NCV at T3, was achieved by MFT (P = 0.015), particularly for sensory neurotoxicity of the peroneal nerve. Also, in respect to the secondary endpoints, significant improvement (P = 0.04) was achieved in terms of the patients’ subjectively perceived neurotoxicity (CTCAE score), but not of neuropathic pain (P = 0.11). From data in the randomized study presented here, a positive effect on the reduction of neurotoxicity can be assumed for the MFT device. Patients with sensory neurotoxicity in the lower limbs, especially, should therefore be offered this therapy. Bioelectromagnetics. © 2016 The Authors. Bioelectromagnetics published by Wiley Periodicals, Inc.
- Published
- 2016
36. Rehabilitation von Patienten mit Prostatakarzinom
- Author
-
A. Rogge, J. Böckmann, T. Dauelsberg, Oliver Rick, W. Kämpfer, D.-H. Zermann, W. Hoffmann, and U. Otto
- Subjects
Cancer survivorship ,Gynecology ,medicine.medical_specialty ,Rehabilitation ,business.industry ,Urology ,medicine.medical_treatment ,030232 urology & nephrology ,03 medical and health sciences ,0302 clinical medicine ,030220 oncology & carcinogenesis ,Medicine ,business ,Standard therapy - Abstract
Hintergrund Obwohl sich zahlreiche Fachgruppen als auch die Deutsche Rentenversicherung und die Krankenkassen an der Rehabilitation von Patienten mit Prostatakarzinom beteiligen, existiert fur diese Patienten kein standardisiertes Rehabilitationsprogramm. Daher ist es fur die Zuweiser zur uroonkologischen Rehabilitation, insbesondere die Arzte in den urologischen Akutkliniken, aber auch fur die Betroffenen selbst nicht transparent, welche Leistungen im Rahmen der Rehabilitation angeboten werden. Zurzeit ist es den Rehakliniken noch weitgehend selbst uberlassen, welche Leistungen sie zur Behandlung welcher Beschwerden und sozialen Situationen sowie welche Beratungsangebote sie anbieten.
- Published
- 2016
37. Onkologische Rehabilitation als 'Initialzünder'
- Author
-
Oliver Rick
- Subjects
Gynecology ,03 medical and health sciences ,medicine.medical_specialty ,0302 clinical medicine ,business.industry ,030220 oncology & carcinogenesis ,Medicine ,030204 cardiovascular system & hematology ,business - Abstract
Konzepte zur Nachsorge von Patienten mit Krebserkrankung gewinnen gerade im Hinblick auf die steigende Zahl von Langzeituberlebenden weiter an Relevanz. Mit einer onkologischen Rehabilitation kann der erste Schritt fur die Nachsorge erfolgen. Patienten werden durch praktische Ubungen und Schulungen zu einem kompetenten Umgang mit Herausforderungen und Langzeitfolgen angeleitet.
- Published
- 2016
38. Adressen
- Author
-
Kurt Possinger, Anne Constanze Regierer, Jan Eucker, Annette Dieing, Bernd Flath, Gunnar Folprecht, Michael Geißler, Erhard Hiller, Andreas Hochhaus, Christian Jehn, Ulrich Keilholz, Konrad Klinghammer, Wolfgang Knauf, Hans-Jochem Kolb, Diana Lüftner, Sebastian Maasberg, Matthias Möhlig, Helmut Oettle, Ulrich-Frank Pape, Uwe Platzbecker, Andreas Rank, Peter Reichardt, Oliver Rick, Hanno Riess, Markus Ruhnke, Markus Schaich, Andreas Schalhorn, Ann-Kristin Schmaelter, Alexander Schmittel, Christian Scholz, Hubert Schrezenmeier, Carsten-Oliver Schulz, Katja Sockel, and Bertram Wiedenmann
- Published
- 2018
39. Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 2 with Recommendations for the Therapy of Primary, Recurrent and Advanced Breast Cancer
- Author
-
Michael Denkinger, Hans Helge Bartsch, Tanja Stüber, Ingrid Schreer, Stephanie Stangl, Ulrich Bick, Cordula Petersen, Christoph Honegger, Steffi Jírů-Hillmann, Christian Kubisch, Wolfgang Janni, Ute-Susann Albert, Friedrich Degenhardt, Anja Welt, Christina Gerlach, Hans Tesch, Christoph Thomssen, Ina Kopp, Matthias W. Beckmann, Ulla Henscher, Sara Y. Brucker, Sylvia H. Heywang-Köbrunner, Thomas Langer, Michael Untch, Peter A. Fasching, Nadia Harbeck, Annette Lebeau, Frederik Wenz, Roswita Hung, Peter U. Heuschmann, Thorsten Kühn, Jutta Hübner, Hans-Jürgen Lück, Hartmut Link, Christoph Heitmann, Anke Steckelberg, Oliver Rick, Monika Nothacker, Andrea Hahne, Arno Bücker, Vesna Bjelic-Radisic, Freerk Baumann, Rita K. Schmutzler, Jens Uwe Blohmer, Volker Budach, Andreas Buck, Gudrun Kemper, Reina Tholen, Markus Hahn, Marcus Schmidt, Hans Kreipe, Mathias Krockenberger, Florian Schütz, Eva M. Fallenberg, Diana Lüftner, Jürgen Dunst, Susanne Hirsmüller, Rüdiger Schulz-Wendtland, Jasmin Festl, Achim Wöckel, Anton Scharl, Ute Nöthlings, Friederike Siedentopf, Sibylle Loibl, Joachim Weis, Simone Wesselmann, Petra Feyer, Wilfried Budach, Alexander Katalinic, Katharina Brust, Kerstin Paradies, K. König, Michael P. Lux, Markus Follmann, Rolf Kreienberg, Markus Müller-Schimpfle, Traudl Baumgartner, Tanja Fehm, Dieter Hölzel, Wolfram Trudo Knoefel, Volkmar Müller, Carsten Denkert, Matthias Zaiss, Hans Hauner, Bernd Gerber, Jutta Engel, Andreas Schneeweiss, Elmar Stickeler, Peyman Hadji, Renza Roncarati, Karsten Münstedt, Hans-Peter Sinn, Volker Hanf, Christian Jackisch, Jens Huober, Gunter von Minckwitz, and Volker Möbus
- Subjects
medicine.medical_specialty ,Advanced breast ,Psychological intervention ,Guideline/Leitlinie ,Systemic therapy ,metastasiertes Mammakarzinom ,primary breast cancer ,03 medical and health sciences ,0302 clinical medicine ,Breast cancer ,breast cancer ,Maternity and Midwifery ,Brustkrebs ,Medicine ,primäres Mammakarzinom ,030212 general & internal medicine ,GebFra Science ,Intensive care medicine ,Leitlinie ,therapy ,business.industry ,Tumor biology ,Obstetrics and Gynecology ,Cancer ,Guideline ,medicine.disease ,Metastatic breast cancer ,ddc ,030220 oncology & carcinogenesis ,metastatic breast cancer ,business ,Therapie ,guideline - Abstract
Geburtshilfe und Frauenheilkunde 78(11), 1056-1088 (2018). doi:10.1055/a-0646-4630, Published by Thieme, New York, NY
- Published
- 2018
40. Low frequency magnetic field therapy in patients with cytostatic-induced polyneuropathy: A phase II pilot study
- Author
-
Oliver Rick, Hermann Dertinger, Georg Geiger, and Eberhard Mikus
- Subjects
Chemotherapy ,medicine.medical_specialty ,Physiology ,business.industry ,medicine.medical_treatment ,Biophysics ,Cancer ,General Medicine ,medicine.disease ,Nerve conduction velocity ,Sensory ataxia ,Internal medicine ,Toxicity ,Neuropathic pain ,Magnetic Field Therapy ,Physical therapy ,Medicine ,Radiology, Nuclear Medicine and imaging ,medicine.symptom ,business ,Polyneuropathy - Abstract
Cytostatic-induced polyneuropathy (CIPN) is a common and serious toxicity in tumor patients. Treatment and prophylactic measures are mainly ineffective. Therefore, there is an urgent need to establish a sufficient therapy for pPNP. Between July 2007 and August 2008, 20 patients were treated with low frequency (4–12 Hz) magnetic field therapy (MFT), and neurological examinations were conducted at the trial therapy's beginning, as well as after 3–4 weeks. Standardized testing methods were applied, i.e., the Common Toxicity Criteria questionnaire of the National Cancer Institute and the measurement of nerve conduction velocity (NCV) in the electrophysiological examination. In terms of the components sensory ataxia and neuropathy as well as neuropathic pain, an improvement was achieved using MFT. This effect was confirmed by an increase in NCV. Using low frequency MFT, CIPN was influenced positively on both hands and feet. This could represent a future therapy principle for these patients. Bioelectromagnetics. 36:251–254, 2015. © 2015 Wiley Periodicals, Inc.
- Published
- 2015
41. A guide to the music scene: club crawling in and around town, (New Orleans, LA: includes a listing of music clubs)(Triple-A baseball)(Directory)
- Author
-
Adams, Rock, Rawls, Alex, and Oliver, Rick
- Subjects
Nightclubs -- Directories ,Zydeco music -- Performances ,Blues (Music) -- Performances ,Jazz music -- Performances ,Brass bands -- Performances ,Country music -- Performances ,Rhythm and blues music -- Performances ,Travel, recreation and leisure - Abstract
New Orleans offers a wide spectrum of music in its nightclubs, music clubs and cafes. A brief profile is given of various venues for the following types of music: zydeco and cajun, blues, jazz, rhythm and blues, country and jazz brass band. A directory of these venues is provided.
- Published
- 1996
42. Malignome des Urogenitaltrakts
- Author
-
Oliver Rick
- Subjects
business.industry ,Medicine ,business - Published
- 2017
43. Herausgeber- und Autorenverzeichnis
- Author
-
Kurt Possinger, Anne Regierer, Jan Eucker, Annette Dieing, Bernd Flath, Gunnar Folprecht, Michael Geißler, Erhard Hiller, Andreas Hochhaus, Christian Jehn, Ulrich Keilholz, Konrad Klinghammer, Wolfgang Knauf, Hans-Jochem Kolb, Diana Lüftner, Matthias Möhlig, Helmut Oettle, null Oettle, null Mayer, Ulrich-Frank Pape, Gabriele Pecher, Uwe Platzbecker, Andreas Rank, Peter Reichardt, Oliver Rick, Ebel Fachkliniken, Hanno Riess, Markus Ruhnke, Markus Schaich, Andreas Schalhorn, Alexander Schmittel, Christian Scholz, Hubert Schrezenmeier, Carsten-Oliver Schulz, Bertram Wiedenmann, Isrid Sturm, Dieter Engelhardt, Ralph Naumann, and Peter Schmid
- Published
- 2017
44. Prophylaxe, Diagnostik und Therapie sekundärer Lymphödeme
- Author
-
Oliver Rick, Eva-Maria Kalusche, and Gerhard Adam
- Subjects
Gynecology ,medicine.medical_specialty ,business.industry ,Medicine ,business - Abstract
Das Risiko von Lymphodemen in der Onkologie hat sich in den vergangenen Jahren durch optimierte Operationstechniken und die Behandlung in fruheren Erkrankungsstadien deutlich gebessert. Dennoch sollte man die Gefahr nicht aus den Augen verlieren, denn ein Lymphodem hat deutliche Auswirkungen auf Leistungsfahigkeit und Lebensqualitat der betroffenen Patienten.
- Published
- 2014
45. Orienteering: A Swedish Way of Life.
- Author
-
Oliver, Rick
- Abstract
Orienteering involves navigating over an unfamiliar route with a map and a compass and locating control markers as quickly as possible. Originating in Sweden, orienting began primarily as a military event and has grown into "a sport for all." Suggested activities in orienteering to conduct in school conclude the article. (ERB)
- Published
- 1984
46. Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer
- Author
-
M. De Santis, Renske Altena, Friedemann Honecker, Leendert H. J. Looijenga, J. T. Hartmann, Aleksander Giwercman, R. de Wit, Silke Gillessen, Nicola Nicolai, Thomas Powles, Sophie D. Fosså, Giovanni Rosti, Robert Huddart, Alv A. Dahl, Gabriella Cohn-Cedermark, Jean-Pierre Lotz, Mark Schrader, M.P. Laguna, Gedske Daugaard, T. Tandstad, Richard Cathomas, S. Kliesch, Janine Nuver, Rainer Souchon, Jan Oldenburg, J. W. Oosterhuis, Alan Horwich, Roberto Salvioni, Frank Mayer, Martin Fenner, Andrea Necchi, S. Schweyer, C. Wittekind, Aude Flechon, Peter Albers, Susanne Krege, Jorge Aparicio, Carsten Bokemeyer, Noel W. Clarke, E. Rajpert-De Meyts, Jonas Busch, Klaus-Peter Dieckmann, Jörg Beyer, Axel Heidenreich, M. de Wit, K. Oechsle, U. De Giorgi, Aslam Sohaib, Jourik A. Gietema, Oliver Rick, Anja Lorch, C. Winter, Karim Fizazi, Felix Sedlmayer, Christian Kollmannsberger, J. R. Germá Lluch, Eva Cavallin-Ståhl, J. Claßen, Marcus Hentrich, Medical Oncology, Pathology, Beyer, J, Albers, P, Altena, R, Aparicio, J, Bokemeyer, C, Busch, J, Cathomas, R, Cavallin-Stahl, E, Clarke, Nw, Classen, J, Cohn-Cedermark, G, Dahl, Aa, Daugaard, G, De Giorgi, U, De Santis, M, De Wit, M, De Wit, R, Dieckmann, Kp, Fenner, M, Fizazi, K, Flechon, A, Fossa, Sd, Lluch, Jrg, Gietema, Ja, Gillessen, S, Giwercman, A, Hartmann, Jt, Heidenreich, A, Hentrich, M, Honecker, F, Horwich, A, Huddart, Ra, Kliesch, S, Kollmannsberger, C, Krege, S, Laguna, Mp, Looijenga, Lhj, Lorch, A, Lotz, Jp, Mayer, F, Necchi, A, Nicolai, N, Nuver, J, Oechsle, K, Oldenburg, J, Oosterhuis, Jw, Powles, T, Rajpert-De Meyts, E, Rick, O, Rosti, G, Salvioni, R, Schrader, M, Schweyer, S, Sedlmayer, F, Sohaib, A, Souchon, R, Tandstad, T, Winter, C, and Wittekind, C
- Subjects
medicine.medical_specialty ,consensus conference ,diagnosis ,MEDLINE ,Reviews ,long-term follow-up ,TESTICULAR CANCER ,HIGH-DOSE CHEMOTHERAPY ,POSITRON-EMISSION-TOMOGRAPHY ,Quality of life (healthcare) ,SDG 3 - Good Health and Well-being ,Survivorship curve ,medicine ,Reproductive health ,Gynecology ,late toxic effects ,treatment ,business.industry ,LONG-TERM SURVIVORS ,Treatment burden ,Consensus conference ,Hematology ,RANDOMIZED PHASE-III ,STAGE-I SEMINOMA ,LYMPH-NODE DISSECTION ,RISK-ADAPTED TREATMENT ,Germ cell cancer ,Oncology ,Family medicine ,CISPLATIN-BASED CHEMOTHERAPY ,Survivorship Issues ,germ-cell cancer ,FOLLOW-UP ,business - Abstract
In November 2011, the Third European Consensus Conference on Diagnosis and Treatment of Germ-Cell Cancer (GCC) was held in Berlin, Germany. This third conference followed similar meetings in 2003 (Essen, Germany) and 2006 (Amsterdam, The Netherlands) [Schmoll H-J, Souchon R, Krege S et al. European consensus on diagnosis and treatment of germ-cell cancer: a report of the European Germ-Cell Cancer Consensus Group (EGCCCG). Ann Oncol 2004; 15: 1377-1399; Krege S, Beyer J, Souchon R et al. European consensus conference on diagnosis and treatment of germ-cell cancer: a report of the second meeting of the European Germ-Cell Cancer Consensus group (EGCCCG): part I. Eur Urol 2008; 53: 478-496; Krege S, Beyer J, Souchon R et al. European consensus conference on diagnosis and treatment of germ-cell cancer: a report of the second meeting of the European Germ-Cell Cancer Consensus group (EGCCCG): part II. Eur Urol 2008; 53: 497-513]. A panel of 56 of 60 invited GCC experts from all across Europe discussed all aspects on diagnosis and treatment of GCC, with a particular focus on acute and late toxic effects as well as on survivorship issues. The panel consisted of oncologists, urologic surgeons, radiooncologists, pathologists and basic scientists, who are all actively involved in care of GCC patients. Panelists were chosen based on the publication activity in recent years. Before the meeting, panelists were asked to review the literature published since 2006 in 20 major areas concerning all aspects of diagnosis, treatment and follow-up of GCC patients, and to prepare an updated version of the previous recommendations to be discussed at the conference. In addition, similar to 50 E-vote questions were drafted and presented at the conference to address the most controversial areas for a poll of expert opinions. Here, we present the main recommendations and controversies of this meeting. The votes of the panelists are added as online supplements.
- Published
- 2013
47. Electron Densities in H ii Regions from Observation of [N ii] 205 μm Fine Structure and Radio Recombination Lines
- Author
-
Paul. F. Goldsmith, L. D. Anderson, Jorge L. Pineda, Rebeca Aladro, and Oliver Ricken
- Subjects
H II regions ,Astrophysics ,QB460-466 - Abstract
We employ observations of the 205 μ m [N ii ] fine structure (FS) line and radio recombination line (RRL) emission to derive the electron density in 10 well-known H ii regions. The combination of these two spectral lines (the RRL–FS line method) provides a sensitive probe of electron density in regions with n (e) ≥ 30 cm ^−3 without requiring knowledge of the size of the ionized region. By using H54 α data from the Green Bank Telescope and 205 μ m data from the SOFIA Airborne Observatory, we have almost identical 18″ beamwidths, removing a significant source of error for observations of H ii regions due to nonuniform density across the sources observed. The electron densities vary widely among the sources observed, from 2600 to 36,000 cm ^−3 , with two low-density outliers at 94 and 520 cm ^−3 . On average, these densities are a factor of 4 greater than the highest-resolution single-antenna data and a factor of almost 13 greater than the 182″ angular resolution single-antenna data having more sources in common. The total 1 σ fractional uncertainties in n (e) are in the range 0.15–0.29. In the RRL–FS line method, the observationally determined quantity is proportional to ∫ n ^2 ( z ) dz / ∫ n ( z ) dz . For a Gaussian density distribution much more extended than its 1/ e radius, this is equal to ${n}_{0}/\sqrt{2}$ , where n _0 is the peak electron density. The high values of electron density found are plausibly the result of the RRL–FS line technique sampling the peak of a centrally condensed density distribution.
- Published
- 2024
- Full Text
- View/download PDF
48. [Rehabilitation of prostate cancer patients : A multidisciplinary consensus]
- Author
-
Oliver, Rick, J, Böckmann, T, Dauelsberg, W, Hoffmann, W, Kämpfer, U, Otto, A, Rogge, and D, Zermann
- Subjects
Male ,Patient Care Team ,Germany ,Urology ,Practice Guidelines as Topic ,Rehabilitation ,Humans ,Prostatic Neoplasms ,Medical Oncology ,Referral and Consultation ,Patient Care Planning - Abstract
Even though several specialist groups, including the German Pension Insurance (Deutsche Rentenversicherung) and health insurance funds, participate in the rehabilitation of patients with prostate carcinoma, there is no standardized rehabilitation program available for these patients. Consequently, there is no transparency regarding the services provided within the scope of rehabilitation for the referring physicians to uro-oncological rehabilitation, in particular, neither for physicians at urological acute-care clinics, nor for the patients concerned. Rehabilitation clinics are rather left to their own devices as to which services they provide in the treatment of the respective disease and in social situations, but also with regard to the consulting services offered.Development of a standard for the rehabilitation of patients with prostate carcinoma, taking into account both specialist circles and self-help groups relevant to this matter.Specialist groups, including self-help groups participating in the rehabilitation of patients with prostate cancer, have formed an expert group and developed the present standard. To this end, a thematic unsystematic literature review was carried out in advance to provide an evidence-based foundation.Views were given with regard to rehabilitation diagnostics, the therapy of urinary incontinence and erectile dysfunction, sport and physical exercise therapy, psycho-oncology, and social- and disease-related consulting. In this context, the focus was set on classification as well as on the consensus strength of the respective recommendations.All parties involved in the rehabilitation of prostate cancer patients, as well as the patients and the responsible cost bearers, can now use the standard as an orientation guide.
- Published
- 2016
49. Magnetic field therapy in patients with cytostatics-induced polyneuropathy: A prospective randomized placebo-controlled phase-III study
- Author
-
Oliver, Rick, Ulrike, von Hehn, Eberhard, Mikus, Hermann, Dertinger, and Georg, Geiger
- Subjects
Adult ,Male ,cancer rehabilitation ,Endpoint Determination ,magnetic field therapy ,Middle Aged ,Cytostatic Agents ,chemotherapy ,Polyneuropathies ,Treatment Outcome ,Humans ,Female ,Prospective Studies ,polyneuropathy ,CIPN ,Research Articles ,Aged ,Research Article - Abstract
No causal treatment for chemotherapy‐induced peripheral neuropathy (CIPN) is known. Therefore, there is an urgent need to develop a therapy for CIPN. Only scarce clinical data are available concerning magnetic field therapy (MFT) in this context. We conducted a unicentric, randomized, double‐blind, placebo‐controlled phase‐III trial of an MFT device versus placebo. In this study, we randomized 44 patients with CIPN to two treatment groups, where 21 patients were treated with MFT (Group 1) and 23 patients received placebo (Group 2). We evaluated the efficacy of MFT at baseline (T1), after 3 weeks of study treatment (T2), and after 3 months of study treatment (T3). The primary endpoint was nerve conduction velocity (NCV), while secondary endpoints were the Common Toxicity Criteria (CTCAE) score and the Pain Detect End Score at T3. Seventeen of the patients in Group 1 and 14 patients in Group 2 completed the respective study treatment. The primary endpoint, significant improvement of NCV at T3, was achieved by MFT (P = 0.015), particularly for sensory neurotoxicity of the peroneal nerve. Also, in respect to the secondary endpoints, significant improvement (P = 0.04) was achieved in terms of the patients’ subjectively perceived neurotoxicity (CTCAE score), but not of neuropathic pain (P = 0.11). From data in the randomized study presented here, a positive effect on the reduction of neurotoxicity can be assumed for the MFT device. Patients with sensory neurotoxicity in the lower limbs, especially, should therefore be offered this therapy. Bioelectromagnetics. 38:85–94, 2017. © 2016 The Authors. Bioelectromagnetics published by Wiley Periodicals, Inc.
- Published
- 2016
50. European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I
- Author
-
Robert Huddart, Johannes Classen, Roberto Salvioni, Rainer Souchon, Walter Albrecht, Xavier Garcia del Muro, Malcolm David Mason, Michael Bamberg, Johnathan Joffe, Jutta Scheiderbauer, Annette Dieing, Oscar Leiva Galvis, Niels E. Skakkebæk, Ronald de Wit, William G. Jones, Sophie D. Fosså, Kai Uwe Koehrmann, H. G. Derigs, Silke Gillessen, Martin Fenner, Sergei Tjulandin, C Clemm, Wolfgang Hoeltl, Padraig Warde, Aude Flechon, Luis Paz Ares, Pieter H.M. De Mulder, S. Kliesch, Nicola Nicolai, Thomas Powles, László Kisbenedek, Lothar Weissbach, Craig R. Nichols, Hans von der Maase, Michael Jewett, Jörg Pont, Markus A. Kuczyk, Volker Loy, Christian Wittekind, Peter Albers, Jose Ramon Germa-Lluch, Felix Sedlmayer, Giovanni Rosti, D. Ondruš, Pilar Laguna, Heinz Schmidberger, István Bodrogi, Gabriella Cohn-Cedermark, Eva Cavallin-Ståhl, Jörg Beyer, Tim Oliver, Arthur Gerl, Gedske Daugaard, Stefan Weinknecht, Tobias Pottek, Hans-Joachim Schmoll, Maike de Wit, Rolf Mueller, Maria De Santis, Michael Hartmann, Graham M. Mead, Oliver Rick, Jean Pierre Droz, Christian K. Kollmannsberger, Hans U. Schmelz, Karim Fizazi, Gosse O N Oosterhof, Lori Wood, Thomas Gauler, Aslam Sohaib, Susanne Krege, Ferran Algaba, Alan Horwich, Eva Winter, Stéphane Culine, Giorgio Pizzocaro, Olbjørn Klepp, Axel Heidenreich, Klaus Peter Dieckmann, Jörg T. Hartmann, Mark Schrader, Lajos Géczi, Carsten Bokemeyer, Department of Urology, Klinikum Kassel GmbH, Department of Molecular Genetics and Department of Chemotherapy, National Institute of Oncology, Endocrinologie moléculaire et cellulaire des cancers, Université Montpellier 1 (UM1)-Institut National de la Santé et de la Recherche Médicale (INSERM), Département d'oncologie Médicale, CRLCC Val d'Aurelle - Paul Lamarque, Dept of Oncology, Rigshospitalet [Copenhagen], Copenhagen University Hospital-Copenhagen University Hospital, Science et Ingénierie des Matériaux et Procédés (SIMaP), Université Joseph Fourier - Grenoble 1 (UJF)-Institut polytechnique de Grenoble - Grenoble Institute of Technology (Grenoble INP )-Institut National Polytechnique de Grenoble (INPG)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS), Génomes et cancer (GC (FRE2939)), Université Paris-Sud - Paris 11 (UP11)-Institut Gustave Roussy (IGR)-Centre National de la Recherche Scientifique (CNRS), Departments of Clinical Cancer Research and genetics, Rikshospitalet-Radiumhospitalet Trust, Commissariat à l'énergie atomique et aux énergies alternatives - Laboratoire d'Electronique et de Technologie de l'Information (CEA-LETI), Direction de Recherche Technologique (CEA) (DRT (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA), Institut de biologie moléculaire des plantes (IBMP), Centre National de la Recherche Scientifique (CNRS)-Université de Strasbourg (UNISTRA), Dept of Urological Oncology, Phillips university, Academic Radiotherapy Unit, Institute of cancer research, Princess Margaret Hospital, University of Toronto, Department of Chemistry [Rochester], University of Rochester [USA], Department of Medical Oncology, Barts and The London Queen Mary's School of Medicine, Laboratoire Evolution, Génomes et Spéciation (LEGS), Centre National de la Recherche Scientifique (CNRS), Laboratory of Clinical Genetics, Institute of Clinical Oncology, Université de Strasbourg (UNISTRA)-Centre National de la Recherche Scientifique (CNRS), and Medical Oncology
- Subjects
Male ,MESH: Combined Modality Therapy ,Biopsy ,Consensus Development Conferences as Topic ,030232 urology & nephrology ,Membrane transport and intracellular motility [NCMLS 5] ,MESH: Biopsy ,0302 clinical medicine ,Stage I Seminoma ,MESH: Practice Guidelines as Topic ,Medicine ,Societies, Medical ,MESH: Testicular Neoplasms ,Consensus conference ,MESH: Neoplasm Staging ,Neoplasms, Germ Cell and Embryonal ,Prognosis ,Primary tumor ,Combined Modality Therapy ,3. Good health ,Europe ,030220 oncology & carcinogenesis ,Practice Guidelines as Topic ,MESH: Neoplasms, Germ Cell and Embryonal ,medicine.medical_specialty ,[SDV.OT]Life Sciences [q-bio]/Other [q-bio.OT] ,Consensus ,Urology ,MESH: Societies, Medical ,MEDLINE ,MESH: Prognosis ,03 medical and health sciences ,SDG 3 - Good Health and Well-being ,Testicular Neoplasms ,Interventional oncology [UMCN 1.5] ,Humans ,MESH: Consensus ,Testicular cancer ,Neoplasm Staging ,Gynecology ,MESH: Humans ,business.industry ,MESH: Consensus Development Conferences as Topic ,medicine.disease ,MESH: Male ,Clinical trial ,Germ cell cancer ,Family medicine ,Germ cell tumors ,MESH: Europe ,business - Abstract
Objectives: The first consensus report presented by the European Germ Cell Cancer Consensus Group (EGCCCG) in the year 2004 has found widespread approval by many colleagues throughout the world. In November 2006, the group met a second time under the auspices of the Department of Urology of the Amsterdam Medical Center, Amsterdam, The Netherlands. Methods: Medical oncologists, urological surgeons, radiation oncologists as well as pathologists from several European countries reviewed and discussed the data that had emerged since the 2002 conference, and incorporated the new data into updated and revised guidelines. As for the first meeting, the methodology of evidence-based medicine (EBM) was applied. The results of the discussion were compiled by the writing committee. All participants have agreed to this final update. Results: The first part of the consensus paper describes the clinical presentation of the primary tumor, its treatment, the importance and treatment of testicular intraepithelial neoplasia (TIN), histological classification, staging and prognostic factors, and treatment of stage I seminoma and non-seminoma. Conclusions: Whereas the vast majority of the recommendations made in 2004 remain valid 3 yr later, refinements in the treatment of early- and advanced-stage testicular cancer have emerged from clinical trials. Despite technical improvements, expert clinical skills will continue to be one of the major determinants for the prognosis of patients with germ cell cancer. In addition, the particular needs of testicular cancer survivors have been acknowledged. (C) 2007 European Association of Urology. Published by Elsevier B.V. All rights reserved.
- Published
- 2008
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.